Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in TRAW — Traws Pharma, Inc.

CIK 1533421 NEW YORK, NY
Back to TRAW Full portfolio

Position in TRAW

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$4,319
-$2,935 QoQ
Shares Held
5,142
+29.7% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 34 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TRAW Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,738,477 across 465 Biotechnology names. TRAW ranks #372 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 4,547 $4,218,570
2 BBIO
BridgeBio Pharma, Inc.
 38,206 $2,845,582
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 34,537 $2,815,110
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,292 $2,131,964
5 MDGL
Madrigal Pharmaceuticals, Inc.
 3,927 $2,108,602
6 AXSM
Axsome Therapeutics, Inc.
 6,437 $1,575,584
7 INSM
INSMED Inc
 10,927 $1,165,036
8 ROIV
Roivant Sciences Ltd.
 32,746 $1,158,880

All Filings in TRAW

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,319 5,142
2026-03-31 $7,254 3,964
2025-06-30 $1,044 706
2025-03-31 $7,500 3,261
2024-09-30 $2,227 379
2024-06-30 $1,578 3,508
2024-03-31 $3,521 3,487
2023-12-31 $2,661 3,549
2023-09-30 $2,685 3,782
2023-06-30 $4,186 3,548
2023-03-31 $3,828 5,245
2022-03-31 $2,721 1,479
2021-12-31 $7,894 3,096
2021-09-30 $22,439 5,859
2021-06-30 $291 42